195 related articles for article (PubMed ID: 17407138)
1. Risk factors for malignancy in Japanese renal transplant recipients.
Imao T; Ichimaru N; Takahara S; Kokado Y; Okumi M; Imamura R; Namba Y; Isaka Y; Nonomura N; Okuyama A
Cancer; 2007 May; 109(10):2109-15. PubMed ID: 17407138
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
Tang H; Chelamcharla M; Baird BC; Shihab FS; Koford JK; Goldfarb-Rumyantzev AS
Clin Transplant; 2008; 22(3):263-72. PubMed ID: 18482047
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
5. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C
Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
[TBL] [Abstract][Full Text] [Related]
6. Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation.
Fraile P; García-Cosmes P; Martín P; García-Bernalt V; Tabernero JM
Transplant Proc; 2009; 41(6):2433-4. PubMed ID: 19715943
[TBL] [Abstract][Full Text] [Related]
7. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
[TBL] [Abstract][Full Text] [Related]
9. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
Fan Y; Xiao YB; Weng YG
Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736
[TBL] [Abstract][Full Text] [Related]
11. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
[TBL] [Abstract][Full Text] [Related]
12. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
McGeown MG; Douglas JF; Middleton D
Clin Transpl; 2000; ():193-202. PubMed ID: 11512313
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and prognosis for proteinuria in renal transplant recipients.
Sancho A; Gavela E; Avila A; Morales A; Fernández-Nájera JE; Crespo JF; Pallardo LM
Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
[TBL] [Abstract][Full Text] [Related]
14. Malignancies in renal transplantation: an unmet medical need.
Dantal J; Pohanka E
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
[TBL] [Abstract][Full Text] [Related]
15. Risk of fractures after renal transplantation in the United States.
Nikkel LE; Hollenbeak CS; Fox EJ; Uemura T; Ghahramani N
Transplantation; 2009 Jun; 87(12):1846-51. PubMed ID: 19543063
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant de novo malignancies in renal transplant recipients: the past and present.
Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW
Transpl Int; 2006 Aug; 19(8):607-20. PubMed ID: 16827677
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
Montagnino G; Lorca E; Tarantino A; Bencini P; Aroldi A; Cesana B; Braga M; Lonati F; Ponticelli C
Clin Transplant; 1996 Oct; 10(5):461-9. PubMed ID: 8930463
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality.
Bunnapradist S; Neri L; Wong W; Lentine KL; Burroughs TE; Pinsky BW; Takemoto SK; Schnitzler MA
Am J Kidney Dis; 2008 Mar; 51(3):478-86. PubMed ID: 18295064
[TBL] [Abstract][Full Text] [Related]
19. Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation.
Akbarzadehpasha A; Oliaei F; Asrari MR; Alizadeh-Navaei R
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1044-7. PubMed ID: 21060171
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of new-onset diabetes mellitus after renal transplantation.
Chien YS; Chen YT; Chuang CH; Cheng YT; Chuang FR; Hsieh H
Transplant Proc; 2008 Sep; 40(7):2409-11. PubMed ID: 18790250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
